Thirty-One-Day Target: Drug Therapy as a Subsequent Treatment

(redirected from 31-Day Target: Drug Therapy as a subsequent treatment)

Thirty-One-Day Target: Drug Therapy as a Subsequent Treatment

A cancer target (standard) promulgated by the NHS as of 2009, which requires that all subsequent drug treatments (not just first definitive treatment) are subject to a 3- day standard (target—i.e., the patient receiving adjuvant chemotherapy post-surgery) and must receive the therapy (e.g., hormonal or chemo) within 31 days of the decision to treat has been made. As with the other post-2009 targets, the cancer care team cannot adjust for patient non-attendance (did not attend—DNA), patient cancellation or medical suspension. Pauses (“stopping the clock”) are only allowed for patients being treated electively (i.e., as an inpatient or day case).